Jade Biosciences, Inc.
JBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001798749
No open-market purchases or sales by Jade Biosciences, Inc. insiders were filed in the last 90 days; 153 institutions reported holding it in 13F filings for Q2 2026, worth $1.62B in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Jade Biosciences, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +6 vs. Q3 2021
- Shares held
- 25.6M
- +3.93M (+18.1%) vs. Q3 2021
- Total value
- $301.6M
- −$151.0M (−33.4%) vs. Q3 2021
- New holders
- 12
- 16 more added
- Sold out
- 6
- 9 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 153 | $1.62B |
| Q1 2026 | 120 | $700.3M |
| Q4 2025 | 105 | $726.3M |
| Q3 2025 | 78 | $272.9M |
| Q2 2025 | 75 | $315.1M |
| Q1 2025 | 82 | $79.6M |
| Q4 2024 | 80 | $79.9M |
| Q3 2024 | 75 | $57.8M |
| Q2 2024 | 81 | $45.1M |
| Q1 2024 | 81 | $841.5M |
| Q4 2023 | 64 | $637.8M |
| Q3 2023 | 58 | $386.3M |
| Q2 2023 | 60 | $488.3M |
| Q1 2023 | 66 | $524.1M |
| Q4 2022 | 70 | $802.9M |
| Q3 2022 | 56 | $447.4M |
| Q2 2022 | 51 | $403.0M |
| Q1 2022 | 46 | $475.5M |
| Q4 2021 | 47 | $301.6M |
| Q3 2021 | 41 | $452.6M |
| Q2 2021 | 18 | $454.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Jade Biosciences, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ra Capital Management, L.P. | 8,263,982 | $97.4M | 1.72% | 00.0% | Unchanged |
| Sofinnova Investments, Inc. | 3,758,686 | $44.3M | 2.84% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 3,103,879 | $36.6M | 3.36% | +3,103,879 | New |
| Baker Bros. Advisors LP | 1,831,789 | $21.6M | 0.11% | +179,618+10.9% | Added |
| Cormorant Asset Management, LP | 1,830,691 | $21.6M | 1.28% | −200,000−9.8% | Reduced |
| Citadel Advisors LLC | 1,597,479 | $18.8M | 0.02% | +2,666+0.2% | Added |
| TCG Crossover Management, LLC | 853,330 | $10.1M | 4.71% | +853,330 | New |
| BlackRock Inc. | 729,808 | $8.61M | 0.00% | +246,790+51.1% | Added |
| FMR LLC | 718,351 | $8.47M | 0.00% | 00.0% | Unchanged |
| OUP Management Co., LLC | 603,762 | $7.12M | 3.21% | +603,762 | New |
| OrbiMed Advisors LLC | 535,714 | $6.32M | 0.08% | 00.0% | Unchanged |
| Vanguard Group Inc | 468,315 | $5.52M | 0.00% | −313,060−40.1% | Reduced |
| Sectoral Asset Management Inc | 282,764 | $3.33M | 0.50% | −58,603−17.2% | Reduced |
| Fred Alger Management, LLC | 167,007 | $1.97M | 0.00% | +167,007 | New |
| Geode Capital Management, LLC | 157,730 | $1.86M | 0.00% | +43,307+37.8% | Added |
| State Street Corp | 154,224 | $1.82M | 0.00% | +28,381+22.6% | Added |
| Norges Bank | 101,505 | $1.20M | 0.00% | +101,505 | New |
| Northern Trust Corp | 87,169 | $1.03M | 0.00% | −1,036−1.2% | Reduced |
| Parkwood LLC | 37,156 | $438.0K | 0.08% | −10,903−22.7% | Reduced |
| Parametric Portfolio Associates LLC | 36,000 | $424.0K | 0.00% | −105,638−74.6% | Reduced |
| HRT Financial LP | 34,854 | $410.0K | 0.00% | +34,854 | New |
| Charles Schwab Investment Management Inc | 24,736 | $292.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 23,813 | $281.0K | 0.00% | +2,022+9.3% | Added |
| Goldman Sachs Group Inc | 18,763 | $221.0K | 0.00% | +18,763 | New |
| Golden State Equity Partners | 15,930 | $188.0K | 0.09% | +15,930 | New |
| Susquehanna International Group, LLP | 15,769 | $186.0K | 0.00% | +15,769 | New |
| Nuveen Asset Management, LLC | 14,318 | $157.0K | 0.00% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 12,941 | $153.0K | 0.00% | +12,941 | New |
| Old Well Partners, LLC | 12,600 | $149.0K | 0.09% | 00.0% | Unchanged |
| Jane Street Group, LLC | 12,415 | $146.0K | 0.00% | +12,415 | New |
| Chicago Partners Investment Group LLC | 14,849 | $140.0K | 0.01% | −1,227−7.6% | Reduced |
| Bank of America Corp | 9,515 | $112.0K | 0.00% | +8,634+980.0% | Added |
| Morgan Stanley | 7,951 | $94.0K | 0.00% | +5,210+190.1% | Added |
| Deutsche Bank AG | 6,106 | $72.0K | 0.00% | +312+5.4% | Added |
| JPMorgan Chase & Co | 6,012 | $71.0K | 0.00% | +770+14.7% | Added |
| California State Teachers Retirement System | 5,922 | $70.0K | 0.00% | +477+8.8% | Added |
| American International Group, Inc. | 5,354 | $63.0K | 0.00% | −161−2.9% | Reduced |
| New York State Common Retirement Fund | 4,770 | $56.0K | 0.00% | +2,970+165.0% | Added |
| Wells Fargo & Company | 4,470 | $52.0K | 0.00% | +4,415+8,027.3% | Added |
| Citigroup Inc | 3,468 | $41.0K | 0.00% | +2,319+201.8% | Added |
| Tower Research Capital LLC (TRC) | 3,124 | $37.0K | 0.00% | +2,710+654.6% | Added |
| STRS Ohio | 2,300 | $27.0K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2,263 | $26.0K | 0.00% | +1,009+80.5% | Added |
| Allspring Global Investments Holdings, LLC | 1,097 | $12.0K | 0.00% | +1,097 | New |
| Legal & General Group Plc | 941 | $11.0K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 772 | $9.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 484 | $6.00K | 0.00% | −607−55.6% | Reduced |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −714,285−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −69,867−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −53,872−100.0% | Sold out |
| Darwin Global Management, Ltd. | 0 | $0 | 0.00% | −12,484−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −775−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −285−100.0% | Sold out |